✦ LIBER ✦

Antileukemic activity and mechanism of action of cordycepin against terminal deoxynucleotidyl transferase-positive (TdT+) leukemic cells

✍ Scribed by Eiichi N Kodama; Ronald P McCaffrey; Keisuke Yusa; Hiroaki Mitsuya

Book ID: 113994656
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 341 KB
Volume: 59
Category: Article
ISSN: 0006-2952
DOI: 10.1016/s0006-2952(99)00325-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of antileukemic agents on the ac

Effects of antileukemic agents on the activity of terminal deoxynucleotidyl transferase from human normal thymic and leukemic cells “in vitro”

✍ Régine Rusquet; Dominique Maniey; Thérése Bassez; Jean-Claude David 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 605 KB

Terminal deoxynucleotidyl transferase in

Terminal deoxynucleotidyl transferase in AKR leukemic cells and lack of relation of enzyme activity to cell cycle phase

✍ Thomas A. Harrison; Ronald D. Barr; Ronald P. McCaffrey; Gregory Sarna; Allen E. 📂 Article 📅 1976 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Terminal deoxynucleotidyl transferase ac

Terminal deoxynucleotidyl transferase activity and cell surface antigens of two unique cell lines (nalm-1 and balm-2) of human leukemic origin

✍ B. I. Sahai Srivastava; J. Minowada 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 French ⚖ 651 KB

## Abstract Two unique cell lines, NALM‐1 and BALM‐2 derived from lymphoblast‐like cells of chronic myelogenous leukemia and rare B cell acute lymphoblastic leukemia patients, respectively, were compared with fresh parent cells from the patients and with a Philadelphia chromosome positive K‐562 cel

Antitumor activity and mechanism of acti

Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells

✍ Egarit Noulsri; Des R. Richardson; Surada Lerdwana; Suthat Fucharoen; Tetsuo Yam 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB 👁 2 views

## Abstract Iron chelators have been reported to induce apoptosis and cell cycle arrest in cancer cells. Recent studies suggest broad and selective antitumor activity of the new iron chelator, di‐2‐pyridylketone‐4,4‐dimethyl‐3‐thiosemicarbazone (Dp44mT; Whitnall et al., Proc Natl Acad Sci USA 2006;